Cipla medicine used for

Topiramate Generic name: topiramate [ toe-PYRE-a-mate] Brand names: Trokendi XR, Topiragen, Topiramate ER (Eqv-Trokendi XR) Dosage forms: oral capsule (15 mg; 25 mg), oral capsule, extended release (100 mg; 150 mg; 200 mg; 25 mg; 50 mg), oral solution (25 mg/mL), oral tablet (100 mg; 200 mg; 25 mg; 50 mg) Drug class: • • • • • • • Related/similar drugs Warnings Topiramate may cause vision problems that can be permanent if not treated quickly. Call your doctor right away if you have a sudden decrease in vision. Topiramate can increase body temperature and decrease sweating, which may lead to life-threatening Tell your doctor if you have decreased sweating, high fever, and hot dry skin. Some people have thoughts about suicide while taking seizure medicine. Stay Before taking this medicine You should not use topiramate if you are allergic to it. Do not take Trokendi XR within 6 hours before or 6 hours after drinking alcohol. Tell your doctor if you are sick with • • • kidney disease, • lung disease, breathing problems; • mood problems, • liver disease; • a growth disorder; or • soft or brittle bones ( Topiramate can increase the level of acid in your blood (metabolic Some people have thoughts about suicide while taking an anticonvulsant. Your doctor should check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms. Taking topiramate during pregnancy may increase the risk of cleft lip and/or cleft palate, a b...

17 Marketing Authorization Holder and Manufacturer 125 micrograms/doseinhalation spray,suspension fluticasone propionate 1. What Fluticasone Cipla is and what it is used for This medicine contains the active substance fluticasone propionate which belongs to the group ofcorticosteroids.Fluticasone Cipla works by reducinginflammationin the lungs.This helps prevent asthma attacks in people who need regular treatment.It takes 4-7 days before the medicine has a full effect and you must use it regularly. Fluticasone Cipla does not help with acute asthma attacks as you feel short of breath.Another drug is used to treat acute attacks. Fluticasone propionate contained in Fluticasone Cipla may also be approved for the treatment of other conditions not mentioned in this leaflet.Ask your doctor, pharmacist, or another healthcare professional if you have any further questions, and always follow their instructions. What you need to know before using Fluticasone Cipla Do not use Fluticasone Cipla – if you are allergic to fluticasone propionate or any of the other ingredients of this medicine (listed in section 6). Warnings and cautions Discontinue treatment with Fluticasone Cipla immediately – if you experience difficulty breathing with wheezing that worsens immediately after taking adoseof this medicine Talk to your doctor, pharmacist, or nurse before using Fluticasone Cipla – if you have ever been treated fortuberculosis(TB) – if you have or have haddiabetes mellitus(becausefluticasone...

Description and Brand Names Drug information provided by: US Brand Name • Viramune • Viramune OS • Viramune XR Descriptions Nevirapine is used in combination with other medicines for the treatment of the infection caused by human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by lowering the amount of HIV in the blood. Nevirapine will not cure HIV infection or AIDS, however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems that usually result from AIDS or HIV disease. Nevirapine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have some of the problems usually related to AIDS or HIV disease. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: • Tablet, Extended Release • Tablet • Suspension • Portions of this document last updated: June 01, 2023 Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. • •

Cipla-Loperamide Cipla-Loperamide inhibits the peristaltic activity of longitudinal and circular smooth muscle in the intestine by interacting with cholinergic and noncholinergic neuronal mechanisms responsible for producing the peristaltic reflex. Cipla-Loperamide binds to the opiate receptor in the gut wall, reducing propulsive peristalsis, and increase intestinal transit time.Cipla-Loperamide is orally administered capsule. After administration absorption is more than 65% which occurs at a modest rate, with peak serum levels of 2-3 µgm/litre occurring at about 4 hours later after oral administration. The rest 35% is excreted unchanged in the faeces. Cipla-Loperamide undergoes an extensive presystemic first pass metabolism in the gut wall and in the liver. Cipla-Loperamide does not act centrally due to its high affinity for the gut wall and its presystemic metabolism. This is why it reaches the systemic circulation in very minute amount. The route of elimination is 0.63-1.4% in urine as unchanged drug, 58% is excreted in the bile and 15-23% appears in the faeces. Cipla-Loperamide is a synthetic anti-diarrheal indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. Cipla-Loperamide is also indicated for reducing the volume of discharge from ileostomies. In man, Cipla-Loperamide prolongs the transit time of the intestinal contents. It reduces the daily fecal volume, increases the vis...